Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lotus Pharma receives Chinese approval to initiate phase-I trials of asthma drug R-bambuterol
Lotus Pharma receives Chinese approval to initiate phase-I trials of asthma drug R-bambuterol
Lotus Pharma receives Chinese approval to initiate phase-I trials of asthma drug R-bambuterol
Submitted by
admin
on October 30, 2010 - 1:09pm
Source:
PharmaBiz
News Tags:
Lotus
R-bambuterol hydrochloride
asthma
Headline:
Lotus Pharma receives Chinese approval to initiate phase-I trials of asthma drug R-bambuterol
Do Not Allow Advertisers to Use My Personal information
